197 related articles for article (PubMed ID: 12673805)
41. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations.
Fernandez-Valero EM; Ballart A; Iturriaga C; Lluch M; Macias J; Vanier MT; Pineda M; Coll MJ
Clin Genet; 2005 Sep; 68(3):245-54. PubMed ID: 16098014
[TBL] [Abstract][Full Text] [Related]
42. The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature.
Thompson AS; Saba N; McReynolds LJ; Munir S; Ahmed P; Sajjad S; Jones K; Yeager M; Donovan FX; Chandrasekharappa SC; Alter BP; Savage SA; Rehman S
Mol Genet Genomic Med; 2021 Jul; 9(7):e1693. PubMed ID: 33960719
[TBL] [Abstract][Full Text] [Related]
43. Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.
Ganesh S; Shoda K; Amano K; Uchiyama A; Kumada S; Moriyama N; Hirose S; Yamakawa K
Mol Cell Probes; 2001 Oct; 15(5):281-9. PubMed ID: 11735300
[TBL] [Abstract][Full Text] [Related]
44. VACTERL with hydrocephalus in twins due to Fanconi anemia (FA): mutation in the FAC gene.
Cox PM; Gibson RA; Morgan N; Brueton LA
Am J Med Genet; 1997 Jan; 68(1):86-90. PubMed ID: 8986283
[TBL] [Abstract][Full Text] [Related]
45. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.
Yang Y; Kuang Y; Montes De Oca R; Hays T; Moreau L; Lu N; Seed B; D'Andrea AD
Blood; 2001 Dec; 98(12):3435-40. PubMed ID: 11719385
[TBL] [Abstract][Full Text] [Related]
46. Ataxia-telangiectasia in the Japanese population: identification of R1917X, W2491R, R2909G, IVS33+2T-->A, and 7883del5, the latter two being relatively common mutations.
Fukao T; Song XQ; Yoshida T; Tashita H; Kaneko H; Teramoto T; Inoue R; Katamura K; Mayumi M; Hiratani M; Taniguchi N; Arai J; Wakiguchi H; Bar-Shira A; Shiloh Y; Kondo N
Hum Mutat; 1998; 12(5):338-43. PubMed ID: 9792410
[TBL] [Abstract][Full Text] [Related]
47. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain.
Callén E; Casado JA; Tischkowitz MD; Bueren JA; Creus A; Marcos R; Dasí A; Estella JM; Muñoz A; Ortega JJ; de Winter J; Joenje H; Schindler D; Hanenberg H; Hodgson SV; Mathew CG; Surrallés J
Blood; 2005 Mar; 105(5):1946-9. PubMed ID: 15522956
[TBL] [Abstract][Full Text] [Related]
48. Novel Founder Mutation in
Dimishkovska M; Kotori VM; Gucev Z; Kocheva S; Polenakovic M; Plaseska-Karanfilska D
Balkan Med J; 2018 Jan; 35(1):108-111. PubMed ID: 29400309
[TBL] [Abstract][Full Text] [Related]
49. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
[TBL] [Abstract][Full Text] [Related]
50. Four novel mutations in the thiazide-sensitive Na-Cl co-transporter gene in Japanese patients with Gitelman's syndrome.
Maki N; Komatsuda A; Wakui H; Ohtani H; Kigawa A; Aiba N; Hamai K; Motegi M; Yamaguchi A; Imai H; Sawada K
Nephrol Dial Transplant; 2004 Jul; 19(7):1761-6. PubMed ID: 15069170
[TBL] [Abstract][Full Text] [Related]
51. Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype correlation in 38 classical citrullinemia patients.
Gao HZ; Kobayashi K; Tabata A; Tsuge H; Iijima M; Yasuda T; Kalkanoglu HS; Dursun A; Tokatli A; Coskun T; Trefz FK; Skladal D; Mandel H; Seidel J; Kodama S; Shirane S; Ichida T; Makino S; Yoshino M; Kang JH; Mizuguchi M; Barshop BA; Fuchinoue S; Seneca S; Zeesman S; Knerr I; Rodés M; Wasant P; Yoshida I; De Meirleir L; Abdul Jalil M; Begum L; Horiuchi M; Katunuma N; Nakagawa S; Saheki T
Hum Mutat; 2003 Jul; 22(1):24-34. PubMed ID: 12815590
[TBL] [Abstract][Full Text] [Related]
52. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.
Levitus M; Waisfisz Q; Godthelp BC; de Vries Y; Hussain S; Wiegant WW; Elghalbzouri-Maghrani E; Steltenpool J; Rooimans MA; Pals G; Arwert F; Mathew CG; Zdzienicka MZ; Hiom K; De Winter JP; Joenje H
Nat Genet; 2005 Sep; 37(9):934-5. PubMed ID: 16116423
[TBL] [Abstract][Full Text] [Related]
53. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance.
Lo Ten Foe JR; Kwee ML; Rooimans MA; Oostra AB; Veerman AJ; van Weel M; Pauli RM; Shahidi NT; Dokal I; Roberts I; Altay C; Gluckman E; Gibson RA; Mathew CG; Arwert F; Joenje H
Eur J Hum Genet; 1997; 5(3):137-48. PubMed ID: 9272737
[TBL] [Abstract][Full Text] [Related]
54. A common founder mutation of CERKL underlies autosomal recessive retinal degeneration with early macular involvement among Yemenite Jews.
Auslender N; Sharon D; Abbasi AH; Garzozi HJ; Banin E; Ben-Yosef T
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5431-8. PubMed ID: 18055789
[TBL] [Abstract][Full Text] [Related]
55. X-linked inheritance of Fanconi anemia complementation group B.
Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H
Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827
[TBL] [Abstract][Full Text] [Related]
56. Four human FANCG polymorphic variants show normal biological function in hamster CHO cells.
Hinz JM; Nham PB; Yamada NA; Tebbs RS; Salazar EP; Hinz AK; Mohrenweiser HW; Jones IM; Thompson LH
Mutat Res; 2006 Dec; 602(1-2):34-42. PubMed ID: 17010390
[TBL] [Abstract][Full Text] [Related]
57. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.
Waisfisz Q; de Winter JP; Kruyt FA; de Groot J; van der Weel L; Dijkmans LM; Zhi Y; Arwert F; Scheper RJ; Youssoufian H; Hoatlin ME; Joenje H
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10320-5. PubMed ID: 10468606
[TBL] [Abstract][Full Text] [Related]
58. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
59. Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg.
van de Vrugt HJ; Koomen M; Berns MA; de Vries Y; Rooimans MA; van der Weel L; Blom E; de Groot J; Schepers RJ; Stone S; Hoatlin ME; Cheng NC; Joenje H; Arwert F
Genes Cells; 2002 Mar; 7(3):333-42. PubMed ID: 11918676
[TBL] [Abstract][Full Text] [Related]
60. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
